BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38592587)

  • 1. Blood vessel organoids generated by base editing and harboring single nucleotide variation in Notch3 effectively recapitulate CADASIL-related pathogenesis.
    Ahn Y; An JH; Yang HJ; Lee WJ; Lee SH; Park YH; Lee JH; Lee HJ; Lee SH; Kim SU
    Mol Neurobiol; 2024 Apr; ():. PubMed ID: 38592587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction of a CADASIL point mutation using adenine base editors in hiPSCs and blood vessel organoids.
    Wang J; Zhang L; Wu G; Wu J; Zhou X; Chen X; Niu Y; Jiao Y; Liu Q; Liang P; Shi G; Wu X; Huang J
    J Genet Genomics; 2024 Feb; 51(2):197-207. PubMed ID: 37164272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy with a Novel NOTCH3 Cys323Trp Mutation Presenting Border-Zone Infarcts: A Case Report and Literature Review.
    Tojima M; Saito S; Yamamoto Y; Mizuno T; Ihara M; Fukuda H
    J Stroke Cerebrovasc Dis; 2016 Aug; 25(8):e128-30. PubMed ID: 27241575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human iPS cell-derived mural cells as an in vitro model of hereditary cerebral small vessel disease.
    Yamamoto Y; Kojima K; Taura D; Sone M; Washida K; Egawa N; Kondo T; Minakawa EN; Tsukita K; Enami T; Tomimoto H; Mizuno T; Kalaria RN; Inagaki N; Takahashi R; Harada-Shiba M; Ihara M; Inoue H
    Mol Brain; 2020 Mar; 13(1):38. PubMed ID: 32188464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)].
    Ueda M; Nakaguma R; Ando Y
    Rinsho Byori; 2009 Mar; 57(3):242-51. PubMed ID: 19363995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
    Ruchoux MM; Domenga V; Brulin P; Maciazek J; Limol S; Tournier-Lasserve E; Joutel A
    Am J Pathol; 2003 Jan; 162(1):329-42. PubMed ID: 12507916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOTCH3 is non-enzymatically fragmented in inherited cerebral small-vessel disease.
    Young KZ; Lee SJ; Zhang X; Cartee NMP; Torres M; Keep SG; Gabbireddy SR; Fontana JL; Qi L; Wang MM
    J Biol Chem; 2020 Feb; 295(7):1960-1972. PubMed ID: 31901894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration of non-myocyte proteins in arterial media of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
    Lee SJ; Kondepudi A; Young KZ; Zhang X; Cartee NMP; Chen J; Jang KY; Xu G; Borjigin J; Wang MM
    PLoS One; 2023; 18(2):e0281094. PubMed ID: 36753487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms regulating cerebral hypoperfusion in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
    Yan X; Shang J; Wang R; Wang F; Zhang J
    J Biomed Res; 2022 Aug; 36(5):353-357. PubMed ID: 36165325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Archetypal Arg169Cys mutation in NOTCH3 does not drive the pathogenesis in cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy via a loss-of-function mechanism.
    Cognat E; Baron-Menguy C; Domenga-Denier V; Cleophax S; Fouillade C; Monet-Leprêtre M; Dewerchin M; Joutel A
    Stroke; 2014 Mar; 45(3):842-9. PubMed ID: 24425116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo Mutation Enables NOTCH3ECD Aggregation and Mitochondrial Dysfunction via Interactions with BAX and BCL-2.
    Liu R; Gao C; Shang J; Sun R; Wang W; Li W; Gao D; Huo X; Shi Y; Wang Y; Wang F; Zhang J
    J Alzheimers Dis; 2022; 86(1):67-81. PubMed ID: 35001891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic antibody targeting of Notch3 signaling prevents mural cell loss in CADASIL.
    Machuca-Parra AI; Bigger-Allen AA; Sanchez AV; Boutabla A; Cardona-Vélez J; Amarnani D; Saint-Geniez M; Siebel CW; Kim LA; D'Amore PA; Arboleda-Velasquez JF
    J Exp Med; 2017 Aug; 214(8):2271-2282. PubMed ID: 28698285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pericytes are involved in the pathogenesis of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
    Ghosh M; Balbi M; Hellal F; Dichgans M; Lindauer U; Plesnila N
    Ann Neurol; 2015 Dec; 78(6):887-900. PubMed ID: 26312599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CADASIL.
    Wang MM
    Handb Clin Neurol; 2018; 148():733-743. PubMed ID: 29478611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NOTCH3 score: a pre-clinical CADASIL biomarker in a novel human genomic NOTCH3 transgenic mouse model with early progressive vascular NOTCH3 accumulation.
    Rutten JW; Klever RR; Hegeman IM; Poole DS; Dauwerse HG; Broos LA; Breukel C; Aartsma-Rus AM; Verbeek JS; van der Weerd L; van Duinen SG; van den Maagdenberg AM; Lesnik Oberstein SA
    Acta Neuropathol Commun; 2015 Dec; 3():89. PubMed ID: 26715087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and characterization of the human iPSC line IDISi001-A isolated from blood cells of a CADASIL patient carrying a NOTCH3 mutation.
    Fernández-Susavila H; Mora C; Aramburu-Núñez M; Quintas-Rey R; Arias S; Collado M; López-Arias E; Sobrino T; Castillo J; Dell'Era P; Campos F
    Stem Cell Res; 2018 Apr; 28():16-20. PubMed ID: 29414412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CADASIL: A NOTCH3-associated cerebral small vessel disease.
    Yuan L; Chen X; Jankovic J; Deng H
    J Adv Res; 2024 Jan; ():. PubMed ID: 38176524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct phenotypic and functional features of CADASIL mutations in the Notch3 ligand binding domain.
    Monet-Leprêtre M; Bardot B; Lemaire B; Domenga V; Godin O; Dichgans M; Tournier-Lasserve E; Cohen-Tannoudji M; Chabriat H; Joutel A
    Brain; 2009 Jun; 132(Pt 6):1601-12. PubMed ID: 19293235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic NOTCH3 cysteine correction in CADASIL using exon skipping: in vitro proof of concept.
    Rutten JW; Dauwerse HG; Peters DJ; Goldfarb A; Venselaar H; Haffner C; van Ommen GJ; Aartsma-Rus AM; Lesnik Oberstein SA
    Brain; 2016 Apr; 139(Pt 4):1123-35. PubMed ID: 26912635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequestration of latent TGF-β binding protein 1 into CADASIL-related Notch3-ECD deposits.
    Kast J; Hanecker P; Beaufort N; Giese A; Joutel A; Dichgans M; Opherk C; Haffner C
    Acta Neuropathol Commun; 2014 Aug; 2():96. PubMed ID: 25190493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.